Aadi Bioscience, Inc. ( AADI) - Key Metrics
Stock symbol AADI is outdated, potentially delisted? Maybe it is available on other exchange?
AADI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.29 | -$0.51 | -$0.92 | -$0.83 |
| 2024Q2 | $0.23 | -$0.54 | -$0.34 | -$0.36 |
| 2024Q1 | $0.20 | -$0.68 | -$0.73 | -$0.76 |
| 2023Q4 | $0.23 | -$0.60 | -$0.36 | -$0.39 |
| 2023Q3 | $0.22 | -$0.60 | -$0.44 | -$0.48 |
AADI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.02 |
| 2024Q2 | ? | -0.66 |
| 2024Q1 | ? | -0.85 |
| 2023Q4 | ? | -0.84 |
| 2023Q3 | ? | -2.00 |
AADI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -40.19% | ? |
| 2024Q2 | -25.29% | ? |
| 2024Q1 | -32.72% | ? |
| 2023Q4 | -19.20% | ? |
| 2023Q3 | -10.01% | ? |
AADI
Price: $2.05
52 week price:
Earnings Per Share: -2.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52100
Market Capitalization: 94.9 million